We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Inclusion of Elderly Patients Urged in EMA Cancer Drug Development Guidance
Inclusion of Elderly Patients Urged in EMA Cancer Drug Development Guidance
February 11, 2013
The European Medicines Agency (EMA) has finalized a revised guideline on anticancer drug development, placing special emphasis on the inclusion of elderly patients in clinical trials.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor